Over-the-Counter (OTC) Markets in Australia: 2026 Guide

The OTC market refers to the trading of financial instruments directly between two parties, rather than through a centralised exchange. These instruments can include shares of unlisted companies, bonds, derivatives, foreign currencies, and even some cryptocurrencies. Trades are typically facilitated through broker-dealer networks or electronic trading platforms, rather than being matched by a central exchange.

Examples of OTC products:

• Unlisted company shares
• Government and corporate bonds
• Foreign currencies
• Derivatives (such as options and swaps)
• Certain managed funds and green bonds

Key participants:

• Institutional investors
• Brokers and dealers
• Sophisticated retail investors
• Companies seeking capital outside traditional exchanges

The Australian OTC market has evolved rapidly, driven by advances in electronic trading and ongoing regulatory developments. Electronic platforms now play a central role in facilitating OTC trades, making the market more efficient and accessible. At the same time, regulatory bodies such as the Australian Securities and Investments Commission (ASIC) have introduced measures to improve transparency and investor protection, particularly in areas like OTC derivatives and foreign exchange (FX) trading.

Electronic Trading Platforms

In 2026, electronic platforms are the primary venue for OTC trading in Australia. Well-established systems are widely used for trading a range of OTC products, and there is growing adoption of technologies such as blockchain for settlement and verification. These platforms have helped streamline the process, reduce settlement times, and improve record-keeping.

Regulatory Oversight

ASIC continues to play an active role in overseeing the OTC market. Recent updates to the OTC Derivative Transaction Rules require real-time reporting of trades above certain thresholds. These measures are designed to reduce the risk of market abuse and improve transparency for all participants. Regulatory attention is particularly focused on products that carry higher risks for retail investors, such as contracts for difference (CFDs) and certain types of derivatives.

Common OTC Products in Australia

The OTC market in Australia covers a wide range of products, including:

• Foreign exchange (FX) contracts
• Contracts for difference (CFDs)
• Unlisted managed funds
• Some green bonds and sustainability-linked instruments

For example, a company might raise capital by issuing bonds directly to institutional investors via an OTC platform, avoiding the costs and requirements of a public exchange listing.

The flexibility of the OTC market is both its main advantage and its primary risk. For sophisticated investors, OTC products can offer access to a broader range of assets, early-stage ventures, and tailored financial solutions that are not available on public exchanges.

Potential Benefits

• Wider asset choices: Investors can access products not listed on formal exchanges.
• Bespoke deals: OTC trades can be customised to suit the needs of both parties.
• Pricing opportunities: In some cases, large or complex transactions may be negotiated at more favourable terms.

Key Risks

• Lower liquidity: OTC products may be harder to buy or sell quickly at a fair price.
• Counterparty risk: Since trades are made directly between parties, there is a risk that one side may default on their obligations.
• Less regulatory protection: OTC markets are generally less regulated than public exchanges, which can increase the risk for investors.
• Opaque pricing: Without centralised price discovery, it can be harder to determine fair value.

ASIC has issued warnings to retail investors about the risks of high-leverage OTC derivative products, particularly those promoted through online channels. Enforcement actions have targeted providers who make misleading claims or do not adequately assess whether clients understand the risks involved.

OTC markets are no longer the exclusive domain of large institutions, but they are not suitable for everyone. In 2026, ASIC requires brokers to conduct stricter suitability checks for retail clients. Everyday investors must demonstrate their understanding of OTC products before gaining access. For businesses and sophisticated investors, OTC markets remain a valuable avenue for raising capital, managing risk, and accessing tailored financial solutions.

Typical OTC users include:

• Businesses seeking flexible funding options
• Exporters and importers managing currency risk
• Investors looking for diversification beyond listed markets

Growth in ESG and Green Finance

There is increasing interest in environmental, social, and governance (ESG) products within the OTC market. Green bonds and sustainability-linked derivatives are becoming more common, reflecting a broader push towards climate-aligned finance from both investors and regulators.

Crypto OTC Trading

With regulatory changes affecting cryptocurrency exchanges, more Australian investors are turning to regulated OTC desks for large crypto transactions. These desks can offer greater privacy and flexibility for significant trades, while still operating within the regulatory framework.

Technology and Automation

Advancements in technology continue to reshape the OTC landscape. Automation, artificial intelligence for risk management, and blockchain-based settlement systems are all contributing to more efficient and secure trading environments. These changes are expected to accelerate in the coming years, further transforming how OTC products are traded and settled.

• Regulatory developments: Ongoing changes to ASIC rules may affect which products are available and how they are traded.
• Product innovation: New types of OTC instruments, particularly in the ESG and digital asset space, are likely to emerge.
• Market access: Suitability requirements for retail investors may continue to evolve, affecting who can participate in OTC trading.

The OTC market in Australia offers a diverse range of opportunities for investors and businesses in 2026. While it provides access to products and deals not available on public exchanges, it also comes with distinct risks—especially for those unfamiliar with its workings. Staying informed about regulatory changes and understanding the unique characteristics of OTC products are essential steps for anyone considering this part of the financial market.